2015
DOI: 10.1002/14651858.cd005248.pub3
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous in-line filters for preventing morbidity and mortality in neonates

Abstract: This is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2015, Issue 8. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(22 citation statements)
references
References 35 publications
0
22
0
Order By: Relevance
“…Furthermore, in-line IV filters add cost [ 19 21 ]. Some reports have suggested the benefit of in-line IV filters [ 1 , 20 , 22 , 23 ], whereas other reports have rejected their routine use [ 3 , 24 26 ]. To date, the routine use of in-line IV filters is not standard.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, in-line IV filters add cost [ 19 21 ]. Some reports have suggested the benefit of in-line IV filters [ 1 , 20 , 22 , 23 ], whereas other reports have rejected their routine use [ 3 , 24 26 ]. To date, the routine use of in-line IV filters is not standard.…”
Section: Discussionmentioning
confidence: 99%
“…63 For instance, in-line filters did not significantly influence the incidence of bloodstream infections, phlebitis, morbidity, and mortality. [64][65][66] Nevertheless, according to most national recommendations in Europe, there is a role for the use of in-line filtration of TNA for patients who require intensive parenteral therapy; the immunocompromised, neonates, and children might have increased susceptibility to the detrimental effects of particulate contamination and therefore can benefit from the use of filters during the administration of PN. 31,33,[67][68][69] In such cases, 0.22-μm filters should be used for lipid-free admixtures and 1.2-μm filters for lipidcontaining admixtures.…”
Section: Ile Administrationmentioning
confidence: 99%
“…The administration of these particles can have serious consequences for the patient, as endothelial lesions and thrombosis [21,22], and the use of inline filters has been shown to reduce the number of general complications and Systemic Inflammatory Response Syndrome (SIRS) [23]. However, a recent meta-analysis did not reveal a significant effect of online filters on overall mortality in pediatrics/neonatology [24]. Not all drugs are filterable, such as suspensions, micellar solutions, liposomes, having a high viscosity or a risk of adsorption on the filter membrane.…”
Section: Factorsmentioning
confidence: 99%